Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Breast Computed Tomography (CT) as a Diagnostic Tool

Completed

Conditions: Breast Cancer

First Posted Date: 2009-08-12

Last Posted Date: 2015-07-23

Lead Sponsor: Emory University

Target Recruit Count: 16

Registration Number: NCT00957307

Locations: 🇺🇸
Emory University Hospital Breast Imaging Center, Atlanta, Georgia, United States

Comparison Study of Breast Computed Tomography (CT) With Magnetic Resonance Imaging (MRI)

Completed

Conditions: Breast Cancer

First Posted Date: 2009-08-12

Last Posted Date: 2013-09-12

Lead Sponsor: Emory University

Target Recruit Count: 2

Registration Number: NCT00957099

Locations: 🇺🇸
Emory University Hospital Breast Imaging Center, Atlanta, Georgia, United States

Assessment of Systemically Administered Torisel Delivery to Brain Tumors by Intratumoral Microdialysis

Phase 1

Withdrawn

Conditions: Brain Neoplasms

Interventions: Drug: Temsirolimus (Torisel)

First Posted Date: 2009-07-30

Last Posted Date: 2013-11-21

Lead Sponsor: Emory University

Registration Number: NCT00949026

Locations: 🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States

Exemestane or Docetaxel-Cytoxan in Low Recurrence Score Cancers

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: Docetaxel
Drug: Exemestane
Drug: Cytoxan

First Posted Date: 2009-07-17

Last Posted Date: 2017-04-10

Lead Sponsor: Emory University

Target Recruit Count: 31

Registration Number: NCT00941330

Locations: 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States

Magnetic Resonance Imaging (MRI) to Evaluate Brain Injury in Congenital Heart Disease

Completed

Conditions: Neonatal Congenital Heart Disease

First Posted Date: 2009-07-03

Last Posted Date: 2016-02-10

Lead Sponsor: Emory University

Target Recruit Count: 92

Registration Number: NCT00932633

Locations: 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States

Effect of Thiazolidinediones on Human Bone

Not Applicable

Completed

Conditions: Osteoblast
Osteocalcin
Adiponectin
Adipocytes
Bone Density
Mesenchymal Stem Cells

Interventions: Drug: Pioglitazone
Drug: Placebo

First Posted Date: 2009-06-25

Last Posted Date: 2016-03-29

Lead Sponsor: Emory University

Target Recruit Count: 10

Registration Number: NCT00927355

Locations: 🇺🇸
Grady Diabetes Clinic, Atlanta, Georgia, United States

Impact of Vitamin D Supplementation on Host Immunity to Mycobacterium Tuberculosis and Response to Treatment

Phase 2

Completed

Conditions: Tuberculosis

Interventions: Dietary Supplement: Placebo
Dietary Supplement: Vitamin D pill

First Posted Date: 2009-06-11

Last Posted Date: 2014-07-11

Lead Sponsor: Emory University

Target Recruit Count: 199

Registration Number: NCT00918086

Locations: 🇬🇪
National Center for tuberculosis and Lung diseases, Tbilisi, Georgia

Vitamin D and Arteriovenous Fistulae

Not Applicable

Completed

Conditions: End-stage Renal Disease

Interventions: Drug: Placebo
Drug: Vitamin D3

First Posted Date: 2009-06-03

Last Posted Date: 2014-07-02

Lead Sponsor: Emory University

Target Recruit Count: 52

Registration Number: NCT00912782

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States

Phase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: Everolimus
Biological: Trastuzumab

First Posted Date: 2009-06-03

Last Posted Date: 2018-12-05

Lead Sponsor: Emory University

Target Recruit Count: 70

Registration Number: NCT00912340

Locations: 🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, United States

and more 1 locations

TT-CMV Observational Birth Cohort Study

Completed

Conditions: Cytomegalovirus Disease

First Posted Date: 2009-05-22

Last Posted Date: 2015-06-26

Lead Sponsor: Emory University

Target Recruit Count: 600

Registration Number: NCT00907686

Locations: 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Northside Hospital, Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy